PRICE T ROWE ASSOCIATES INC /MD/ - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 85 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q4 2021. The put-call ratio across all filers is 1.95 and the average weighting 0.0%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q4 2022$6
-99.9%
56,3100.0%0.00%
Q3 2022$10,000
-28.6%
56,3100.0%0.00%
Q2 2022$14,000
-44.0%
56,310
+21.3%
0.00%
Q1 2022$25,000
+38.9%
46,410
+55.7%
0.00%
Q4 2021$18,000
-37.9%
29,810
+4.9%
0.00%
Q3 2021$29,000
-44.2%
28,4100.0%0.00%
Q2 2021$52,000
+126.1%
28,410
+148.3%
0.00%
Q1 2021$23,000
+64.3%
11,441
+5.4%
0.00%
Q4 2020$14,000
-93.2%
10,853
-90.5%
0.00%
Q3 2020$206,000
-78.6%
114,5530.0%0.00%
Q2 2020$961,000
+61.2%
114,553
+0.7%
0.00%
Q1 2020$596,000
-1.5%
113,752
+2.6%
0.00%
Q4 2019$605,000
+7.5%
110,852
-4.2%
0.00%
Q3 2019$563,000
-15.2%
115,700
+20.8%
0.00%
Q2 2019$664,000
+16.5%
95,811
+16.9%
0.00%
Q1 2019$570,000
+8.0%
81,983
-9.4%
0.00%
Q4 2018$528,000
-2.9%
90,483
+25.5%
0.00%
Q3 2018$544,000
+49.9%
72,084
+0.4%
0.00%
Q2 2018$363,000
-34.2%
71,783
-20.7%
0.00%
Q1 2018$552,000
+14.5%
90,528
+33.5%
0.00%
Q4 2017$482,000
+285.6%
67,834
+287.1%
0.00%
Q3 2017$125,00017,5240.00%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q4 2021
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 5,045,870$6,307,0004.30%
ETF MANAGERS GROUP, LLC 8,103,641$10,130,0000.22%
AdvisorShares Investments LLC 271,873$340,0000.08%
Platform Technology Partners 60,000$75,0000.04%
PINNACLE ASSOCIATES LTD 942,079$1,178,0000.02%
HRT FINANCIAL LP 883,510$1,104,0000.02%
Virtu Financial LLC 153,908$192,0000.02%
Tekla Capital Management LLC 413,481$517,0000.02%
Aries Wealth Management 23,400$33,0000.02%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 56,932$71,0000.02%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders